Eli Lilly’s Billion-Dollar Leap: Pharma Innovation Takes Off in Hyderabad to Transform India’s Drug Manufacturing!

Eli Lilly announced a major investment exceeding $1 billion in India to set up a state-of-the-art manufacturing and quality facility in Hyderabad. This new site will support contract drug manufacturing and bolster the company’s global supply chain. The Hyderabad facility aims to leverage advanced technologies like AI, automation, and cloud computing, further establishing Hyderabad as a global pharma innovation hub. Lilly’s initiative aligns with expanding collaborations with Indian contract drugmakers, enhancing accessibility to vital medications. This investment marks a key step in strengthening Eli Lilly’s presence and capabilities in one of the world’s fastest-growing pharmaceutical markets.

 

Key Points:

Sources: Reuters, Times of India, Bioprocess International, Medstown